BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9742770)

  • 21. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
    de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New therapeutic principle in the management of cardiac insufficiency: A II antagonists. Results of the ELITE study (Evaluation of Losartan In The Elderly)].
    Dtsch Med Wochenschr; 1997 Sep; 122(39 Suppl):1-4. PubMed ID: 9351465
    [No Abstract]   [Full Text] [Related]  

  • 25. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure.
    Carson PE
    Am Heart J; 2000 Sep; 140(3):361-6. PubMed ID: 10966531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The curtain rises on the renin-angiotensin system: AT2 receptors are in the spotlight.
    Douglas JG
    J Clin Invest; 1996 Apr; 97(8):1787. PubMed ID: 8621760
    [No Abstract]   [Full Text] [Related]  

  • 27. The development of nonpeptide angiotensin II receptor antagonists: a success story.
    Höltje HD; Jessen G; Höltje M
    Pharmazie; 1997 Feb; 52(2):83-6. PubMed ID: 9122281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal and humoral pathophysiological actions of angiotensin II in congestive heart failure.
    Mirzoyev Z; Anavekar NS; Chen HH
    Drugs Today (Barc); 2005 Feb; 41(2):129-39. PubMed ID: 15821784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Receptors for vasoactive peptides in experimental hypertension and cardiac insufficiency].
    Schiffrin EL; St-Louis J
    Union Med Can; 1988 Feb; 117(1):133-6. PubMed ID: 2836981
    [No Abstract]   [Full Text] [Related]  

  • 30. [New therapeutic perspectives associated with the introduction of angiotensin II receptor antagonists].
    Peczkowska M; Kabat M; Janaszek-Sitkowska H
    Pol Arch Med Wewn; 1997 Apr; 97(4):379-90. PubMed ID: 9411416
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renin-angiotensin system in congestive heart failure].
    Kai H; Imaizumi T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():143-8. PubMed ID: 15813059
    [No Abstract]   [Full Text] [Related]  

  • 32. Unopposed stimulation of the angiotensin AT2 receptor in the kidney.
    Chung O; Unger T
    Nephrol Dial Transplant; 1998 Mar; 13(3):537-40. PubMed ID: 9550620
    [No Abstract]   [Full Text] [Related]  

  • 33. Costarring statins with ARBs: going to be a smash hit?
    Sanada S; Komuro I
    Circ J; 2011; 75(3):540-1. PubMed ID: 21266784
    [No Abstract]   [Full Text] [Related]  

  • 34. Losartan for therapy of posttransplant erythrocytosis.
    Navarro JF; Macía M; García J
    Clin Nephrol; 1997 Nov; 48(5):335. PubMed ID: 9403221
    [No Abstract]   [Full Text] [Related]  

  • 35. [Perspectives for the Blockade of the Renin-angiotensin-aldesteron System and Modulation of Natriuretic Peptides System in the Treatment of Arterial Hypertension and Heart Failure].
    Kobalava D; Kotovskaya YV; Villevalde SV; Moiseev VS
    Kardiologiia; 2015; 55(6):72-81. PubMed ID: 26625523
    [No Abstract]   [Full Text] [Related]  

  • 36. Signal transduction pathways of angiotensin II in the kidney.
    Bernstein KE; Sayeski PP; Doan T; Farmer PK; Ali MS
    Contrib Nephrol; 2001; (135):16-33. PubMed ID: 11705281
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacology and therapeutics of congestive heart failure.
    Leier CV
    Rev Clin Basic Pharm; 1985; 5(1-2):175-209. PubMed ID: 3916303
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic heart failure].
    Kupari M
    Duodecim; 1985; 101(10):1010-21. PubMed ID: 4006788
    [No Abstract]   [Full Text] [Related]  

  • 39. Principles of drug therapy in heart failure.
    Dey SK; Poflee VW
    Natl Med J India; 1995; 8(2):73-8. PubMed ID: 7735067
    [No Abstract]   [Full Text] [Related]  

  • 40. [The renin-angiotensin system and its receptors].
    Kitami Y; Hiwada K
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():66-70. PubMed ID: 11026237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.